# AIAI Holdings Corp: financial statements, quarterly

AIAI · Nasdaq · CIK 2096362 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/aiai.md) · [Financials](/companies/aiai/financials.md) · [Filings](/companies/aiai/filings.md) · [Insiders](/companies/aiai/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/aiai/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: |
| Revenue | $m | [0.0](/filings/0001193125-26-277544.md) | [65.2](/filings/0001193125-26-352653.md) | [0.0](/filings/0001193125-26-277544.md) |
| Cost of revenue | $m | [0.0](/filings/0001193125-26-277544.md) | [58.3](/filings/0001193125-26-352653.md) | [0.0](/filings/0001193125-26-277544.md) |
| Gross profit | $m | [0.0](/filings/0001193125-26-277544.md) | [6.8](/filings/0001193125-26-352653.md) | [0.0](/filings/0001193125-26-277544.md) |
| Selling, general and administrative | $m | not reported | [5.9](/filings/0001193125-26-352653.md) | not reported |
| Operating income | $m | [0.0](/filings/0001193125-26-277544.md) | [0.9](/filings/0001193125-26-352653.md) | [(2.7)](/filings/0001193125-26-277544.md) |
| Interest expense | $m | not reported | [0.3](/filings/0001193125-26-352653.md) | not reported |
| Income tax | $m | [0.0](/filings/0001193125-26-277544.md) | [0.0](/filings/0001193125-26-352653.md) | [0.0](/filings/0001193125-26-277544.md) |
| Net income | $m | [2.5](/filings/0001193125-26-352653.md) | [0.6](/filings/0001193125-26-352653.md) | [(3.7)](/filings/0001193125-26-352653.md) |
| Diluted EPS | $ per share | [0.00](/filings/0001193125-26-277544.md) | not reported | [(2717.66)](/filings/0001193125-26-277544.md) |
| Basic EPS | $ per share | [0.00](/filings/0001193125-26-277544.md) | not reported | [(2717.66)](/filings/0001193125-26-277544.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2024-12-31) | period not labelled (2025-03-31) | period not labelled (2025-12-31) | Q1 FY2026 (2026-03-31) | period not labelled (2026-05-06) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | [15.6](/filings/0001193125-26-352653.md) | [0.0](/filings/0001193125-26-277544.md) | not reported | [11.2](/filings/0001193125-26-352653.md) |
| Current assets | $m | not reported | not reported | [62.5](/filings/0001193125-26-352653.md) | not reported | not reported | [81.8](/filings/0001193125-26-352653.md) |
| Total assets | $m | not reported | not reported | [94.7](/filings/0001193125-26-352653.md) | [0.0](/filings/0001193125-26-277544.md) | not reported | [1,314](/filings/0001193125-26-352653.md) |
| Current liabilities | $m | not reported | not reported | [53.7](/filings/0001193125-26-352653.md) | [2.4](/filings/0001193125-26-277544.md) | not reported | [108](/filings/0001193125-26-352653.md) |
| Total liabilities | $m | not reported | not reported | [79.7](/filings/0001193125-26-352653.md) | [2.4](/filings/0001193125-26-277544.md) | not reported | [318](/filings/0001193125-26-352653.md) |
| Long-term debt | $m | not reported | not reported | [22.3](/filings/0001193125-26-352653.md) | not reported | not reported | [18.9](/filings/0001193125-26-352653.md) |
| Current portion of debt | $m | not reported | not reported | [1.8](/filings/0001193125-26-352653.md) | not reported | not reported | [7.8](/filings/0001193125-26-352653.md) |
| Short-term borrowings | $m | not reported | not reported | [0.0](/filings/0001193125-26-352653.md) | not reported | not reported | [3.0](/filings/0001193125-26-352653.md) |
| Shareholders' equity | $m | [0.0](/filings/0001193125-26-277544.md) | [0.0](/filings/0001193125-26-277544.md) | [15.0](/filings/0001193125-26-352653.md) | [(2.4)](/filings/0001193125-26-277544.md) | [(2.8)](/filings/0001193125-26-352653.md) | [996](/filings/0001193125-26-352653.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: |
| Operating cash flow | $k | [0.0](/filings/0001193125-26-277544.md) | [8,759 d](/filings/0001193125-26-352653.md) | [(1,730)](/filings/0001193125-26-277544.md) |
| Capital expenditure | $k | [0.0](/filings/0001193125-26-277544.md) | [524 d](/filings/0001193125-26-352653.md) | [5.0](/filings/0001193125-26-277544.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | period not labelled (2025-03-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: |
| Diluted shares (weighted) | units of shares | [344](/filings/0001193125-26-277544.md) | [1,000](/filings/0001193125-26-277544.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 70,662,761 at 2026-08-11, from the cover of the [10-Q filed 2026-08-14](/filings/0001193125-26-352653.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:51 ET. No prices; not investment advice.